High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen
出版年份 2014 全文链接
标题
High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 70, Issue 3, Pages 926-929
出版商
Oxford University Press (OUP)
发表日期
2014-11-11
DOI
10.1093/jac/dku439
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
- (2014) I. Malet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
- (2014) A. Castagna et al. JOURNAL OF INFECTIOUS DISEASES
- Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
- (2014) Bonaventura Clotet et al. LANCET
- A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure
- (2013) Anne-Geneviève Marcelin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- HIV-1-infected patients with advanced disease failing a raltegravir-containing salvage regimen in São Paulo, Brazil
- (2013) Jaqueline de Souza Cavalcanti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- In-vivo selection of the mutation F121Y in a patient failing raltegravir containing salvage regimen
- (2012) Jaqueline Souza Cavalcanti et al. ANTIVIRAL RESEARCH
- Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients
- (2012) F. Saladini et al. CLINICAL MICROBIOLOGY AND INFECTION
- Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
- (2011) P. K. Quashie et al. JOURNAL OF VIROLOGY
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation
- (2009) O. Delelis et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More